Why Summit Therapeutics Stock Was Winning This Week
Summit Therapeutics (SMMT) The Motley Fool·2025-03-14 12:13A very bullish analyst move was the news generally responsible for Summit Therapeutics' (SMMT -3.62%) healthy mid-week stock price pop. That upward lift was largely holding as of Friday before market open, as according to data compiled by S&P Global Market Intelligence Summit's share price had risen by almost 8% week to date at that point.The next cancer blockbuster drug?The person behind the news was Evercore ISI pundit Cory Kasimov, who on Wednesday launched coverage of Summit stock. He's quite firmly in ...